Results 61 to 70 of about 2,565 (197)
Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants [PDF]
ABSTRACT Studies performed in several countries have demonstrated the recent emergence and subsequent dominance of circulating Bordetella pertussis strains harboring pertactin and pertussis toxin variants not included in pertussis vaccines. Determination of the pertactin gene variants is commonly performed
Muyldermans, G +9 more
openaire +4 more sources
Goal. Study of the protective activity and safety of acellular pertussis vaccine (APV) using freshly isolated strain of B. pertussis. Materials and methods. Mice-hybrids F1 (CBAxC57Bl6). The B. pertussis strains: vaccine strains No. 305, No. 203, freshly
E. M. Zaitsev +2 more
doaj +1 more source
Isolate-Based Surveillance of Bordetella pertussis, Austria, 2018–2020
Pertussis is a vaccine-preventable disease, and its recent resurgence might be attributable to the emergence of strains that differ genetically from the vaccine strain.
Adriana Cabal +14 more
doaj +1 more source
During 2010 and 2012, California and Vermont, respectively, experienced statewide epidemics of pertussis with differences seen in the demographic affected, case clinical presentation, and molecular epidemiology of the circulating strains.
Katherine E. Bowden +11 more
doaj +1 more source
Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland [PDF]
Despite extensive vaccinations, resurgence of pertussis has been reported in many countries ([9][1]). Recently, emergence of Bordetella pertussis isolates not expressing the vaccine antigen pertactin (Prn) or pertussis toxin was described in France, where surveillance of the clinical isolates ...
Barkoff, A-M +5 more
openaire +5 more sources
Development of High-Throughput Serum Bactericidal Assays for Bordetella pertussis to Evaluate BPZE1
Background/Objectives: Pertussis, caused by Bordetella pertussis, remains a global health problem, despite high vaccine coverage. In countries with high acellular pertussis vaccine (aPV) coverage, pertactin-negative B.
Peter Goldstein +9 more
doaj +1 more source
To clarify the characteristics of circulating Bordetella pertussis isolates, we used pulsed-field gel electrophoresis (PFGE) to analyze 5,262 isolates collected in the United States during 2000–2012.
Pamela K. Cassiday +3 more
doaj +1 more source
Fha Deficient Bordetella pertussis Isolates in Iran with 50 Years Whole Cell Pertussis Vaccination
Background: Bordetella pertussis, a highly contagious respiratory. Notably, the resurgence of pertussis has recently been associated with the lacking production of vaccine virulence factors.
Samaneh Saedi +5 more
doaj +1 more source
Acellular Pertussis Vaccine Components: Today and Tomorrow
Pertussis is a highly communicable acute respiratory infection caused by Bordetella pertussis. Immunity is not lifelong after natural infection or vaccination. Pertussis outbreaks occur cyclically worldwide and effective vaccination strategies are needed
Kalyan K. Dewan +3 more
doaj +1 more source
ABSTRACT Outer membrane vesicles (OMVs) are nanosized vesicles naturally secreted by Gram‐negative bacteria and represent a promising platform for vaccine development. OMVs possess inherent immunostimulatory properties due to the presence of pathogen‐associated molecular patterns (PAMPs), providing self‐adjuvanting capabilities and the ability to ...
Asja Garling +4 more
wiley +1 more source

